Koers TCR2 Therapeutics Inc.
Aandelen
TCRR
US87808K1060
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
William Bertrand
PSD | President | 59 | 01-06-23 |
Robert Tighe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garry Menzel
CEO | Chief Executive Officer | 59 | 01-01-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,14% | 42,11 mld. | |
+49,22% | 40,08 mld. | |
+8,21% | 40 mld. | |
-11,32% | 26,87 mld. | |
+7,04% | 24,58 mld. | |
-21,95% | 18,44 mld. | |
+1,84% | 11,94 mld. | |
+28,72% | 11,66 mld. | |
+8,15% | 11,01 mld. |